Filing Details
- Accession Number:
- 0001209191-17-041790
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-26 08:23:26
- Reporting Period:
- 2017-06-23
- Filing Date:
- 2017-06-26
- Accepted Time:
- 2017-06-26 08:23:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533040 | Rxi Pharmaceuticals Corp | RXII | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1704417 | Gerrit Dispersyn | C/O 257 Simarano Drive, Suite 101 Marlborough MA 01752 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2017-06-23 | 3,500 | $0.62 | 3,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
